ClinicalMetric Research Team · Last Reviewed: April 2026 · Sources: ClinicalTrials.gov · FDA · NIH
◆ Clinical Trial Intelligence — Key Facts
  • 400,000+ active trials registered on ClinicalTrials.gov across 200+ countries (2025)
  • Only ~12% of drugs entering clinical trials ultimately receive FDA approval
  • Average clinical trial takes 6–13 years from Phase 1 to regulatory approval
  • ~40% of trials fail to recruit sufficient participants — the #1 reason trials stop early
  • All trials must register on ClinicalTrials.gov under the FDA Amendments Act (FDAAA 2007)
Back to Insights
Patient Guide Last Reviewed: April 2026 CM-INS-078 // 7 min read // MARCH 2026

Clinical Trials Near Me 2026: How to Find Local Studies and What to Expect

"Clinical trials near me" is one of the most searched patient phrases. This guide explains exactly how to find local trials, what to do when there are none nearby, and how decentralized trial designs in 2026 are making geography less of a barrier than ever before.

Medical Notice

This article is for informational purposes only and does not constitute medical advice. Clinical trial eligibility and availability vary. Always consult a qualified healthcare professional before making any medical decisions or considering participation in a clinical trial.

Quick Summary

There are over 450,000 registered clinical trials worldwide — roughly 60,000 actively recruiting at any time. Proximity matters for frequent visits but is no longer a barrier for many studies. Decentralized trial designs, telemedicine visits, and travel reimbursement programs mean that the right trial for your condition may be hundreds of miles away — and that may still be worth exploring.

Step 1: Search by Location on ClinicalTrials.gov

ClinicalTrials.gov is the world's largest clinical trial registry with over 450,000 studies. To search by location:

  1. Go to clinicaltrials.gov and enter your condition in the search bar
  2. Click "More Filters" and scroll to the Location section
  3. Enter your ZIP code, city, or country and select a distance radius (25, 50, or 100 miles)
  4. Set Status to "Recruiting" — this is critical to filter out completed or not-yet-open studies
  5. Sort by "Relevance" first, then review the trial site locations in each result

Each trial listing shows the recruiting locations as a list of cities, countries, and institutions. A trial may have 20 sites — only one needs to be near you. Always check the full site list before concluding a trial isn't accessible.

Step 2: Understand Visit Frequency Before Applying

Not all trials require the same number of in-person visits. Before dismissing a trial as "too far," check the visit schedule in the protocol summary:

Trial Type Typical Visit Frequency Remote Options
Phase 1 (safety) Weekly or more during dosing Limited — high monitoring needed
Phase 2/3 chronic disease Monthly to quarterly Often available for follow-up visits
Decentralized/hybrid 1–2 in-person, rest remote Yes — home nurse, app, wearables
Observational/registry Annual or survey-based Fully remote common

Step 3: Ask About Travel Reimbursement

Travel costs are one of the biggest barriers to trial participation — but many sponsors cover them. What's reimbursable varies by trial and sponsor, but commonly includes:

  • Mileage or fuel costs for driving to the trial site
  • Public transport fares (train, bus, subway)
  • Hotel accommodation for overnight stays, particularly for distant sites
  • Flights — common in rare disease and oncology trials recruiting nationally
  • Caregiver travel — many trials reimburse one accompanying person
  • Childcare costs — some NIH-funded trials include these in compensation

Travel reimbursement is rarely advertised upfront — always ask the trial coordinator during your pre-screening call. The question to ask: "Does this trial provide travel reimbursement, and what does it cover?"

Decentralized Clinical Trials: When There's No Site Near You

Decentralized clinical trials (DCTs) bring the trial to the patient. In 2026, approximately 40% of new trials incorporate at least some decentralized elements. What this means for you:

  • Home nursing visits: A trained nurse comes to your home for blood draws, vital signs, and drug administration — particularly common in Phase 2 oncology and rare disease trials
  • Telemedicine check-ins: Video calls with the study doctor replace some in-person visits. Safety monitoring labs may be done at a local LabCorp or Quest Diagnostics
  • Study drug delivery: Oral medications shipped directly to your home pharmacy. Injectables may be self-administered after training
  • Wearables and e-diaries: Continuous heart rate monitoring, activity tracking, and smartphone symptom diaries replace clinic-based assessments for many endpoints

When searching for trials, look for terms like "decentralized," "hybrid," "remote," or "home visits" in the protocol description. Sponsors using decentralized designs often explicitly mention them in the eligibility section.

Finding Trials Through Patient Networks

ClinicalTrials.gov is comprehensive but difficult to navigate. Alternative resources for finding local trials:

  • ResearchMatch.org: NIH-funded platform that matches patients to relevant trials through participating university hospitals
  • Patient advocacy organizations: Disease-specific groups (NORD, NAMI, ACS, CCFA) maintain trial locators and can alert you when trials open at nearby sites
  • Academic medical centers: Major university hospitals (Mayo Clinic, Johns Hopkins, UCSF, UCL, Charité) run more trials per institution than community hospitals — worth travelling to for initial evaluation
  • Your specialist: Oncologists, neurologists, and rheumatologists at academic practices are typically connected to research networks and can refer you to trials before they appear publicly on registries

When No Local Trial Exists: Next Steps

Register your interest early. Many trials have a pre-registration or waitlist system. When a new site opens near you, patients who registered interest are contacted first.

Ask about expanded access. If a drug you're interested in is in Phase 3 trials but no site is near you, the manufacturer may offer expanded access (compassionate use) through your own physician. This is not a trial but provides access to the drug before approval.

Consider a one-time distant visit. Some trials allow remote follow-up after an in-person baseline. Flying to a distant site once for enrollment — then completing follow-up via telemedicine — may be worth it for a high-priority treatment.

Search Trials by Location

ClinicalMetric searches 450,000+ trials from ClinicalTrials.gov with cleaner filtering by condition, phase, location, and recruiting status.

Search Trials Near Me → Trial Map →
ClinicalMetric Research Team
Clinical Trial Research & Analysis
Analysis compiled from ClinicalTrials.gov (NIH/NLM), FDA trial registry data, and peer-reviewed clinical research. ClinicalMetric tracks 400,000+ active clinical trials worldwide, updated daily from the ClinicalTrials.gov AACT database.
ClinicalMetric Intelligence Team
Clinical Trial Research & Analysis · Last updated April 2026
Analysis compiled from ClinicalTrials.gov (NIH/NLM), FDA trial registry data, and peer-reviewed clinical research. ClinicalMetric tracks 400,000+ active clinical trials worldwide, updated daily from the ClinicalTrials.gov AACT database.
Get Weekly Clinical Trial Alerts
New recruiting trials from NIH, NCI, and 40+ sponsors — every Monday. Free forever.
◆ Clinical Trial Intelligence at a Glance
400K+
Active trials tracked
200+
Countries with active trials
4
Clinical trial phases
Daily
Data refresh from ClinicalTrials.gov
◆ Clinical Trial Phase Transition Success Rates
Phase 1 → Phase 2 success ~63%
Phase 2 → Phase 3 success ~32%
Phase 3 → Approval ~58%
Overall FDA approval rate ~12%
Source: Biotechnology Innovation Organization (BIO) Clinical Development Success Rates — approximate industry averages.
◆ Clinical Trial Development Timeline
Mo 1–6
Preclinical + IND Filing
Mo 6–18
Phase 1 (Safety)
Mo 18–48
Phase 2 (Efficacy)
Mo 48–84
Phase 3 (Pivotal)
Mo 84–96
FDA Review / NDA
Mo 96+
Approval + Phase 4
Timeline is approximate. Total development from preclinical to approval averages 6–13 years.
About the Author
ClinicalMetric Research Team
Clinical Trial Intelligence Specialists · clinicalmetric.com
Our analysts monitor 400,000+ clinical trials daily across oncology, neurology, cardiology, and rare diseases. All data sourced from ClinicalTrials.gov and FDA.gov.
🔬 400K+ trials tracked 🌍 200+ countries 🔄 Updated: April 2026
◆ Common Questions About Clinical Trials
What is a clinical trial? +
A clinical trial is a research study involving human participants designed to evaluate medical interventions — such as drugs, devices, or behavioral strategies. Trials follow a structured protocol and are registered on ClinicalTrials.gov. They progress through phases: Phase 1 (safety), Phase 2 (efficacy), Phase 3 (large-scale comparison), and Phase 4 (post-market surveillance).
How do I find clinical trials I'm eligible for? +
You can search ClinicalTrials.gov or use ClinicalMetric to filter by condition, phase, or location. Each trial listing includes eligibility criteria such as age range, sex, diagnosis, and prior treatment history. Contact the study team directly or ask your physician to refer you to a relevant trial.
Are clinical trials safe to participate in? +
Clinical trials are conducted under strict ethical and regulatory oversight, including IRB approval and FDA regulation in the US. All participants must give informed consent after reviewing potential risks and benefits. Phase 1 trials carry more uncertainty, while Phase 3 trials involve interventions with an established safety profile. Participation is always voluntary and you may withdraw at any time.
What are the phases of clinical trials? +
Clinical trials progress through four main phases. Phase 1 tests safety and dosing in a small group (20–80 people). Phase 2 evaluates efficacy and side effects in a larger group (100–300). Phase 3 compares the intervention against standard treatments in thousands of participants. Phase 4 occurs after approval and monitors long-term effects in the general population.
Do participants get paid for joining clinical trials? +
Many clinical trials offer compensation for time and travel expenses, though payment structures vary widely by study. Compensation is not intended to be coercive. Some trials also cover treatment costs for participants. Always review the consent form carefully and ask the study coordinator about any financial considerations before enrolling.
Browse by Phase
Phase 1Phase 2Phase 3Phase 4
Browse by Condition
CancerDiabetesAlzheimer'sDepressionHeart DiseaseCOVID-19Parkinson'sMultiple Sclerosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology